2013-01-04 15:36:04 - Research specialist Cobalz is pleased to announce an exclusive agreement with Beaufort Medical LLC, UAE.
Cobalz Limited of 12a WhiteFriars Chester CH1 1NZ ( www.cobalz.co.uk/) has agreed an “Exclusive Distribution Agreement” for the Middle East and North Africa (MENA) with Beaufort Medical LLC, P.O.Box 102723, Dubai, United Arab Emirates, for their Homocysteine reducing Memory Loss Tablet “Betrinac”( www.betrinac.com/).
Beaufort Medical LLC will now be the sole point of contact in MENA for the supply of Betrinac to all Pharmacies throughout Saudi Arabia, United Arab Emirates, Kuwait, Oman, Qatar, Bahrain, Iraq, Egypt, Jordan, Lebanon, Libya, Tunisia, Algeria, Morocco, Syria and Turkey..
Beaufort Medical LLC , established in 2007, is a well known supplier of Pharmaceuticals and medical equipment to retail pharmacies and hospitals.
Their Managing Director is Mr Jihad Fakreddine.
Neil McCaddon Development Director of Cobalz Ltd said
an exciting new development for Cobalz and will help us increase Product awareness and availability of Betrinac throughout the Middle East and North Africa.
We are now actively seeking similar partnerships throughout Europe, Canada and Australia.”
Mr Jihad Fakreddine of Beaufort Medical LLC said:
“We are very pleased to add Betrinac to our Portfolio and look forward to working closely with Cobalz to make Betrinac readily available in the MENA Pharmacies we currently serve.”
For further information please email firstname.lastname@example.org
or you can find out more online at ( www.betrinac.com/
Cobalz specialises in research into B vitamins, homocysteine and dementia. Betrinac is made up of a unique blend of ingredients including Vitamin B6, B12, Folic Acid and the anti-oxidant N-acetylcysteine. This powerful product is designed to aid brain function and maintain performance as you age.
12A White Friars
0800 689 9606